Soluble M1 protein of Streptococcus pyogenes triggers potent T cell activation

被引:42
作者
Pahlman, Lisa I. [2 ]
Olin, Anders I. [2 ]
Darenberg, Jessica [1 ]
Morgelin, Matthias [2 ]
Kotb, Malak [3 ,4 ]
Herwald, Heiko [2 ]
Norrby-Teglund, Anna [1 ]
机构
[1] Karolinska Univ, Huddinge Hosp, Ctr Infect Med, Karolinska Inst, Stockholm, Sweden
[2] Lund Univ, Dept Clin Sci, Sect Clin & Expt Infect Med, Lund, Sweden
[3] Univ Tennessee, Memphis, TN USA
[4] Vet Affairs Med Ctr, Res Serv, Memphis, TN USA
关键词
TOXIC-SHOCK-SYNDROME; GROUP-A STREPTOCOCCI; TUMOR-NECROSIS-FACTOR; POLYSPECIFIC IMMUNOGLOBULIN; BACTERIAL SUPERANTIGENS; CYSTEINE PROTEINASE; CYTOKINE PRODUCTION; TISSUE INFECTIONS; SURFACE-PROTEINS; GENE USAGE;
D O I
10.1111/j.1462-5822.2007.01053.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Streptococcus pyogenes of the M1 serotype is commonly associated with large outbreaks of invasive streptococcal infections and development of streptococcal toxic shock syndrome (STSS). The pathogenesis behind these infections is believed to involve bacterial superantigens that induce potent inflammatory responses, but the reason why strains of the M1 serotype are over-represented in STSS is still not understood. In the present investigation, we show that a highly purified soluble form of the M1 protein from S. pyogenes, which lacks the membrane-spanning region, is a potent inducer of T cell proliferation and release of Th1 type cytokines. M1 protein-evoked T cell proliferation was HLA class II-dependent but not MHC-restricted, did not require intracellular processing and was V beta-restricted. Extensive mass spectrometry studies indicated that there were no other detectable proteins in the preparation. Taken together, our data demonstrate that soluble M1 protein is a novel streptococcal superantigen, which likely contributes to the excessive T cell activation and hyperinflammatory response seen in severe invasive streptococcal infections.
引用
收藏
页码:404 / 414
页数:11
相关论文
共 54 条
[1]   M1-PROTEIN AND PROTEIN-H - IGGFC-BINDING AND ALBUMIN-BINDING STREPTOCOCCAL SURFACE-PROTEINS ENCODED BY ADJACENT GENES [J].
AKESSON, P ;
SCHMIDT, KH ;
COONEY, J ;
BJORCK, L .
BIOCHEMICAL JOURNAL, 1994, 300 :877-886
[2]  
[Anonymous], PSYCHOL DEV SOC, DOI DOI 10.1177/097133369300500204
[3]   Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): Potential impact on the clinical efficacy of IVIG therapy for severe invasive group a streptococcal infections [J].
Basma, H ;
Norrby-Teglund, A ;
McGeer, A ;
Low, DE ;
El-Ahmedy, O ;
Dale, JB ;
Schwartz, B ;
Kotb, M .
INFECTION AND IMMUNITY, 1998, 66 (05) :2279-2283
[4]  
Basma H, 1999, INFECT IMMUN, V67, P1871
[5]   STREPTOCOCCAL CYSTEINE PROTEINASE RELEASES BIOLOGICALLY-ACTIVE FRAGMENTS OF STREPTOCOCCAL SURFACE-PROTEINS [J].
BERGE, A ;
BJORCK, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (17) :9862-9867
[6]   TOXICITY OF RECOMBINANT TOXIC SHOCK SYNDROME TOXIN-1 AND MUTANT TOXINS PRODUCED BY STAPHYLOCOCCUS-AUREUS IN A RABBIT INFECTION MODEL OF TOXIC SHOCK SYNDROME [J].
BONVENTRE, PF ;
HEEG, H ;
CULLEN, C ;
LIAN, CJ .
INFECTION AND IMMUNITY, 1993, 61 (03) :793-799
[7]   Generation of a mature streptococcal cysteine proteinase is dependent on cell wall-anchored M1 protein [J].
Collin, M ;
Olsén, A .
MOLECULAR MICROBIOLOGY, 2000, 36 (06) :1306-1318
[8]   Pathogenesis of group A streptococcal infections [J].
Cunningham, MW .
CLINICAL MICROBIOLOGY REVIEWS, 2000, 13 (03) :470-+
[9]   Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome:: A European randomized, double-blind, placebo-controlled trial [J].
Darenberg, J ;
Ihendyane, N ;
Sjölin, J ;
Aufwerber, E ;
Haidl, S ;
Follin, P ;
Andersson, J ;
Norrby-Teglund, A .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (03) :333-340
[10]   Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden [J].
Darenberg, Jessica ;
Luca-Harari, Bogdan ;
Jasir, Aftab ;
Sandgren, Andreas ;
Pettersson, Helena ;
Schalen, Claes ;
Norgren, Mari ;
Romanus, Victoria ;
Norrby-Teglund, Anna ;
Normark, Birgitta Henriques .
CLINICAL INFECTIOUS DISEASES, 2007, 45 (04) :450-458